Chemours

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Chemours and other ETFs, options, and stocks.

About CC

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductors and consumer electronics, and general industrial. 

CEO
Denise M. Dignam
CEODenise M. Dignam
Employees
5,700
Employees5,700
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
2014
Founded2014
Employees
5,700
Employees5,700

CC Key Statistics

Market cap
2.21B
Market cap2.21B
Price-Earnings ratio
-7.30
Price-Earnings ratio-7.30
Dividend yield
2.40%
Dividend yield2.40%
Average volume
1.82M
Average volume1.82M
High today
$14.85
High today$14.85
Low today
$14.35
Low today$14.35
Open price
$14.48
Open price$14.48
Volume
2.35M
Volume2.35M
52 Week high
$28.67
52 Week high$28.67
52 Week low
$10.44
52 Week low$10.44

Stock Snapshot

The current Chemours(CC) stock price is $14.68, with a market capitalization of 2.21B. The stock trades at a price-to-earnings (P/E) ratio of -7.30 and offers a dividend yield of 2.40%.

On 2026-09-16, Chemours(CC) stock moved within a range of $14.35 to $14.85. With shares now at $14.68, the stock is trading +2.3% above its intraday low and -1.1% below the session's peak.

Trading volume for Chemours(CC) stock has reached 2.35M, versus its average volume of 1.82M.

The stock's 52-week range extends from a low of $10.44 to a high of $28.67.

The stock's 52-week range extends from a low of $10.44 to a high of $28.67.

CC News

Quartz 5d
Chemours, DuPont, Corteva settle North Carolina PFAS claims for $455M - qz.com

...

Chemours, DuPont, Corteva settle North Carolina PFAS claims for $455M - qz.com
Benzinga 6d
Why Is Chemours Stock Trading Higher Today?

The Chemours Company (NYSE:CC) shares traded higher Thursday after the company, DuPont, and Corteva reached a $455 million settlement resolving PFAS-related lit...

Why Is Chemours Stock Trading Higher Today?
TipRanks 6d
Corteva, DuPont, Chemours Settle North Carolina PFAS Claims

Corteva ( (CTVA) ) has provided an announcement. On September 9, 2026, Corteva, DuPont and Chemours reached a comprehensive settlement with the State of North...

Analyst ratings

55%

of 11 ratings
Buy
45.5%
Hold
54.5%
Sell
0%

More CC News

Seeking Alpha 6d
DuPont, Chemours, Corteva reach $455M North Carolina 'forever chemicals' settlement

DuPont de Nemours (DD), Chemours (CC) and Corteva (CTVA) agreed to pay $455 million to settle claims involving PFAS contamination in North Carolina, including d...

DuPont, Chemours, Corteva reach $455M North Carolina 'forever chemicals' settlement
TipRanks 6d
Chemours Reaches Major PFAS Settlement with North Carolina

Chemours Company ( (CC) ) has issued an update. On September 9, 2026, Chemours, together with DuPont and Corteva, reached a $455 million settlement with the St...

TipRanks 6d
Chemours, DuPont and Corteva resolve PFAS claims with $455M settlement

Chemours (CC) announced that, along with DuPont (DD) and Corteva (CTVA), it has entered into a settlement with the State of North Carolina and 11 local entities...

People also own

Based on the portfolios of people who own CC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.